Latest filing published 29 Jul 2021 for Cytocom, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Clifford Selsky: trading record in brief
Clifford Selsky is a declared insider at 2 companies (senior executive); the most frequent names are Cytocom, Inc. and Immune Therapeutics, Inc. Between 8 April 2016 and 27 July 2021, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 29 July 2021 with a share grant in Cytocom, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Clifford Selsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 101,579 shares0Common Stock, par value $0.005 per shareSEC:0001437749-21-017952:0
1 of 1 declaration